Xiang Zhou

16PUBLICATIONS

19CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markersMusic composition and improvisation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (16)

Sort by Publication Date:

|Jun 01, 2026

Sunitinib enhances cuproptosis induced by copper ionophores via ROS-ATF3-SLC31A1 axis in thyroid Carcinoma.

|Feb 26, 2026

EZH2 Inhibition Restores Tumor Suppressor SFRP1 Activity by Reprogramming Extrachromosomal Circular DNA Dynamics in Ovarian Cancer.

Tao Han, Qingya Yan, Yaqi Zhang

|Jan 26, 2026

Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer.

Qian Hao, Yu Gan, Xiang Zhou

|Jan 21, 2026

Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer.

Wei Zhao, Qian Hao, Yu Gan

|Sep 01, 2025

YY1-induced USP43 drives ferroptosis suppression by FASN stabilization and subsequent activation of SLC7A11 in ovarian cancer.

Tianyi Zhao, Xiaojun Chen, Jiangchun Wu

|Apr 08, 2025

p53 transcriptionally activates DCP1B to suppress tumor progression and enhance tumor sensitivity to PI3K blockade in non-small cell lung cancer.

Shiqi Chen, Qian Hao, Yu Gan

Pageof 3

Frequent Collaborators

Qian Hao

Sarit Larisch

Shanshan Wang

Hua Lu

Liping Guan

Tao Han

Wenjie Ren

Keda Yu

Yizhou Jiang

Yingying Xu

Frequent Collaborators

Qian Hao

Sarit Larisch

Shanshan Wang

Hua Lu